Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NextPhase International

www.nextphase.net

Latest From NextPhase International

Singin' the CRO Blues

The big three CROs--Quintiles, Parexel, & Covance have suffered contract cancellations, less-than-glowing earnings reports, and diving stock prices over the last 12 months. But, while the near-term continues to look fairly bleak, there's cause for hope on the horizon. CROs are increasingly seen as strategic partners, rather than as a means of handling overflow. And there's likely to be major opportunities for companies offering specialized services. One particularly promising area involves using the Internet to streamline R&D--for example, web-enabled clinical trials.
BioPharmaceutical Business Strategies

Clinical Trials: Eliminating the Paper Chase

For years, companies have offered remote data entry systems to transfer data from trial sites to a central server. But Big Pharma has by and large stuck to its old-fashioned paper ways. Now several start-ups are offering a new breed of web-based RDE and the pharmaceutical industry is starting to take interest. But before embracing an online approach to data collection, drug companies want proof that doing so will save them time and money. Pharma companies must also evaluate how to integrate data collection and management into the rest of their infrastructures. Collaboration rather than competition might best enable pharmaceutical; companies to fully realize the benefits of web-enabled trials through the cooperative sharing of resources.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NextPhase International
  • Senior Management
  • Michael R Currie, CEO
    Anne M Mastrapa, VP, Corp. Dev. & Mktg.
  • Contact Info
  • NextPhase International
    495 Seaport Court, Suite 102
    Redwood City, CA 94063
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register